Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)
12.73
-0.35 (-2.68%)
Sep 10, 2026, 1:45 PM CST
Jiangsu Yahong Meditech Revenue
Jiangsu Yahong Meditech had revenue of 84.27M CNY in the quarter ending June 30, 2026, with 21.89% growth. This brings the company's revenue in the last twelve months to 302.24M, up 20.27% year-over-year. In the year 2025, Jiangsu Yahong Meditech had annual revenue of 277.12M with 37.49% growth.
Revenue (ttm)
302.24M
Revenue Growth
+20.27%
P/S Ratio
24.39
Revenue / Employee
608.12K
Employees
497
Market Cap
7.37B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 277.12M | 75.56M | 37.49% |
| Dec 31, 2024 | 201.56M | 187.81M | 1,365.55% |
| Dec 31, 2023 | 13.75M | 13.73M | 52,604.89% |
| Dec 31, 2022 | 26.10K | 21.52K | 470.51% |
| Dec 31, 2021 | 4.57K | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Chongqing Taiji Industry(Group) Co.,Ltd | 9.93B |
| China Animal Husbandry Industry | 6.58B |
| Renhe Pharmacy Co.,Ltd | 3.65B |
| Zhejiang Tianyu Pharmaceutical | 3.50B |
| Jiangsu Kanion Pharmaceutical | 3.31B |
| Jiuzhitang | 2.60B |
| Hubei Hongyuan Pharmaceutical Technology | 2.40B |
| Guilin Sanjin Pharmaceutical | 2.02B |